Multicenter, Randomized, Placebo-controlled Crossover Trial Evaluating Topical Lidocaine for Mechanical Cervical Pain
- PMID: 38079112
- DOI: 10.1097/ALN.0000000000004857
Multicenter, Randomized, Placebo-controlled Crossover Trial Evaluating Topical Lidocaine for Mechanical Cervical Pain
Abstract
Background: There are few efficacious treatments for mechanical neck pain, with controlled trials suggesting efficacy for muscle relaxants and topical nonsteroidal anti-inflammatory drugs. Although studies evaluating topical lidocaine for back pain have been disappointing, the more superficial location of the cervical musculature suggests a possible role for topical local anesthetics.
Methods: This study was a randomized, double-blind, placebo-controlled crossover trial performed at four U.S. military, Veterans Administration, academic, and private practice sites, in which 76 patients were randomized to receive either placebo followed by lidocaine patch for 4-week intervals (group 1) or a lidocaine-then-placebo patch sequence. The primary outcome measure was mean reduction in average neck pain, with a positive categorical outcome designated as a reduction of at least 2 points in average neck pain coupled with at least a 5-point score of 7 points on the Patient Global Impression of Change scale at the 4-week endpoint.
Results: For the primary outcome, the median reduction in average neck pain score was -1.0 (interquartile range, -2.0, 0.0) for the lidocaine phase versus -0.5 (interquartile range, -2.0, 0.0) for placebo treatment (P = 0.17). During lidocaine treatment, 27.7% of patients experienced a positive outcome versus 14.9% during the placebo phase (P = 0.073). There were no significant differences between treatments for secondary outcomes, although a carryover effect on pain pressure threshold was observed for the lidocaine phase (P = 0.015). A total of 27.5% of patients in the lidocaine group and 20.5% in the placebo group experienced minor reactions, the most common of which was pruritis (P = 0.36).
Conclusions: The differences favoring lidocaine were small and nonsignificant, but the trend toward superiority of lidocaine suggests more aggressive phenotyping and applying formulations with greater penetrance may provide clinically meaningful benefit.
Similar articles
-
Warm lidocaine/tetracaine patch versus placebo before pediatric intravenous cannulation: a randomized controlled trial.Ann Emerg Med. 2008 Jul;52(1):41-7. doi: 10.1016/j.annemergmed.2008.01.336. Epub 2008 Apr 8. Ann Emerg Med. 2008. PMID: 18395934 Clinical Trial.
-
Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.Clin Drug Investig. 2009;29(6):393-408. doi: 10.2165/00044011-200929060-00003. Clin Drug Investig. 2009. PMID: 19432499 Clinical Trial.
-
Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.Clin J Pain. 2008 Jan;24(1):51-5. doi: 10.1097/AJP.0b013e318156db26. Clin J Pain. 2008. PMID: 18180637 Clinical Trial.
-
Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults.Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD009642. doi: 10.1002/14651858.CD009642.pub3. Cochrane Database Syst Rev. 2018. PMID: 29864216 Free PMC article. Review.
-
Topical lidocaine for neuropathic pain in adults.Cochrane Database Syst Rev. 2014 Jul 24;2014(7):CD010958. doi: 10.1002/14651858.CD010958.pub2. Cochrane Database Syst Rev. 2014. PMID: 25058164 Free PMC article. Review.
Cited by
-
Nerve Preparation and Recordings for Pharmacological Tests of Sensory and Nociceptive Fiber Conduction Ex Vivo.Bio Protoc. 2024 Apr 5;14(7):e4969. doi: 10.21769/BioProtoc.4969. eCollection 2024 Apr 5. Bio Protoc. 2024. PMID: 38618174 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
